NAIOP New Jersey has announced the finalists for its coveted Deal of the Year awards, highlighting six of the state’s most impactful projects and transactions of 2018.
Teva Pharmaceuticals isn’t the only life sciences company to impact New Jersey’s office market this year, as several others have inked sizable leases to expand or upgrade their space.
P3 Properties has made another addition to its New Jersey office portfolio, acquiring a 233,000-square-foot building in Bedminster that is home to a major pharmaceutical company.
New Jersey’s largest office lease of the year to date is official. Brokers with JLL this week announced the completion of Teva Pharmaceuticals USA Inc.’s 345,000-square-foot lease at 400 Interpace Pkwy. in Parsippany, known as MCCBLUE, under a deal with P3 Properties.
Despite new blocks of space hitting the market, New Jersey saw a long-overdue surge of large office leases in the second quarter — with signs that more are on the way.
A real estate investment firm has added to its growing office portfolio in the state, acquiring a piece of the well-known Morris Corporate Center campus in Parsippany.
